{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:10:54Z","timestamp":1777911054231,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["12671697"],"award-info":[{"award-number":["12671697"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.parint.2015.09.004","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T08:27:21Z","timestamp":1442305641000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quantitative assessment of the effects of sulfamethoxazole on  Toxoplasma gondii  loads in susceptible WT C57BL\/6 mice as an immunocompetent host model"],"prefix":"10.1016","volume":"65","author":[{"given":"Usama S.","family":"Belal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Norose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabie M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Nukaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal Z.","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha H.","family":"Abdelgelil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2015.09.004_bb0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0020-7519(98)00023-X","article-title":"Advances in the life cycle of Toxoplasma gondii","volume":"28","author":"Dubey","year":"1998","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.parint.2015.09.004_bb0010","first-page":"447","article-title":"Organ infectivity of Toxoplasma gondii in interferon-\u03b3 knockout mice","volume":"87","author":"Norose","year":"2001","journal-title":"J. Parasitol."},{"key":"10.1016\/j.parint.2015.09.004_bb0015","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1086\/511871","article-title":"Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review","volume":"44","author":"Leal","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2015.09.004_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10072-008-0007-5","article-title":"Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis","volume":"30","author":"Habek","year":"2009","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parint.2015.09.004_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1590\/S0036-46652010000200008","article-title":"Disseminated toxoplasmosis in an immunocompetent patient from Peruvian Amazon","volume":"52","author":"Nunura","year":"2010","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.parint.2015.09.004_bb0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00365548.2012.737017","article-title":"Neuropsychiatric symptoms are common in immunocompetent adult patients with Toxoplasma gondii acute lymphadenitis","volume":"45","author":"Wong","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.parint.2015.09.004_bb0035","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3201\/eid1504.081306","article-title":"Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana","volume":"15","author":"Carme","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.parint.2015.09.004_bb0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.2307\/3284364","article-title":"Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR","volume":"83","author":"Luo","year":"1997","journal-title":"J. Parasitol."},{"key":"10.1016\/j.parint.2015.09.004_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1348-0421.2004.tb03504.x","article-title":"Evaluation of the effects of sulfamethoxazole on Toxoplasma gondii loads and stage conversion in IFN-\u03b3 knockout mice using QC-PCR","volume":"48","author":"Belal","year":"2004","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.parint.2015.09.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2015.06.018","article-title":"Metabolic activation of hepatotoxic drugs (benzbromarone) induce mitochondrial membrane permeability transition","author":"Shirakawa","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.parint.2015.09.004_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1286-4579(00)00318-X","article-title":"Induction of tumor necrosis factor-\u03b1 and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-\u03b3 in genetically resistant BALB\/c mice","volume":"2","author":"Suzuki","year":"2000","journal-title":"Microbes Infect."},{"key":"10.1016\/j.parint.2015.09.004_bb0060","series-title":"Ocular Infection and Immunity","first-page":"1183","article-title":"Toxoplasmosis","author":"Holland","year":"1996"},{"key":"10.1016\/j.parint.2015.09.004_bb0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for ocular toxoplasmosis","volume":"115","author":"Rothova","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.parint.2015.09.004_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis","volume":"134","author":"Silveira","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.parint.2015.09.004_bb0075","first-page":"1","article-title":"Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management","volume":"137","author":"Holland","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.parint.2015.09.004_bb0080","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00417-010-1379-9","article-title":"Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?","volume":"248","author":"Winterhalter","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.parint.2015.09.004_bb0085","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ajo.2013.12.022","article-title":"Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial","volume":"157","author":"Felix","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.parint.2015.09.004_bb0090","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/IAI.00254-08","article-title":"Temporal and spatial distribution of Toxoplasma gondii differentiation into bradyzoites and tissue cyst formation in vivo","volume":"76","author":"Di Cristina","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parint.2015.09.004_bb0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1471-4922(02)02248-1","article-title":"Toxoplasma gondii tachyzoite\u2013bradyzoite interconversion","volume":"18","author":"Lyons","year":"2002","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.parint.2015.09.004_bb0100","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00436-007-0700-y","article-title":"The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8\u2212\/\u2212 mice","volume":"101","author":"Jost","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parint.2015.09.004_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1167\/iovs.05-0751","article-title":"Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-\u03b3 knockout mice","volume":"47","author":"Norose","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.parint.2015.09.004_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/38.1.75","article-title":"Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy","volume":"38","author":"van der Ven","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.parint.2015.09.004_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0924-8579(99)00073-4","article-title":"Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models","volume":"13","author":"Dumas","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.parint.2015.09.004_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008571-199704000-00006","article-title":"NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus","volume":"7","author":"Sabbagh","year":"1997","journal-title":"Pharmacogenetics"}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576915001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576915001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T03:50:27Z","timestamp":1531713027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576915001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1383576915001476"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2015.09.004","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative assessment of the effects of sulfamethoxazole on Toxoplasma gondii loads in susceptible WT C57BL\/6 mice as an immunocompetent host model","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2015.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}